sellWeak10b5-1 plan
R Matthew Neff sold $2,487 of NOTV
director at Inotiv, Inc.. 2,000 shares at an average of $1.24, traded Nov 3, 2025, filed Nov 4, 2025.
Warning score
0Value
$2,487
2,000 shares
Holdings after
153,102
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleDirector
- 0Trade size$2k at market
- 0Share of holdings soldSold 1.3% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001332575-25-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 3, 2025 | SOpen-market sale Common Stock10b5-1 | -2,000 | $1.24 | $2,487 | 153,102 | Nov 4, 2025 |
Related signals
Other insiders at Inotiv, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 17Weak | Inotiv, Inc. | Beth A. Taylor Chief Financial Officer | $846 2,888 shares | -2% | |
| 10Weak | Inotiv, Inc. | John E Sagartz Chief Strategy Officer | $616 2,119 shares | -0% | |
| 20Weak | Inotiv, Inc. | Robert Leasure Jr. President and CEO | $4,964 16,810 shares | -1% | |
| 32Weak | NOTVsell Inotiv, Inc. | Robert Leasure Jr. President and CEO | $57k 113,297 shares | -8% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $1,771 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $2,858 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $3,338 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $3,818 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $3,621 2,000 shares | -1% | |
| 0Weak | Inotiv, Inc. | R Matthew Neff director | $5,246 2,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.